Medicxi Profile
Medicxi

@medicxi

Followers
2K
Following
38
Statuses
437

Life sciences venture capital firm

London, Jersey and Geneva
Joined January 2016
Don't wanna be here? Send us removal request.
@medicxi
Medicxi
@medicxi
7 days
This marks Alys' first clinical study following its $100M seed financing from @medicxi , with multiple proof-of-concept readouts expected across multiple indications in immune-dermatology by 2027
0
0
3
@medicxi
Medicxi
@medicxi
2 months
Ottimo's Series A is led by OrbiMed, Avoro Capital and Samsara BioCapital with participation from RTW Investments, Decheng Capital, Janus Henderson Investors, J.P. Morgan Life Sciences, The Invus Group and Medicxi
0
0
0
@medicxi
Medicxi
@medicxi
4 months
Ottimo is developing Jankistomig, a PD1/VEGFR2 bifunctional antibody, designed to advance the field of cancer immunotherapy by targeting both immune checkpoint inhibition and angiogenesis Jankistomig is in late preclinical development, and is expected to enter the clinic in 2025
0
0
1
@medicxi
Medicxi
@medicxi
5 months
Congratulations to Emmanuel Hanon and the entire Vicebio team on this fantastic milestone!
0
0
0
@medicxi
Medicxi
@medicxi
5 months
Full details these interim Phase 1 results can be found here:
0
0
0
@medicxi
Medicxi
@medicxi
6 months
Congratulations to the Vaderis team!
0
0
1
@medicxi
Medicxi
@medicxi
6 months
RT @RivusPharma: Our Phase 2a HuMAIN trial met primary & secondary endpoints, supporting potential for our investigational therapy to be th…
0
3
0